2m 2m 2m 2m 2m 2m 2m
Ultragenyx Pharm (RARE)
NASDAQ
$14.30-$0.002 (-0.01%)
Price as of Sep 11, 2026 7:56 PM EDT- $1.4BMarket Cap
- -52.82%1-Year Change
- BiotechnologyIndustry
Ultragenyx Pharm (RARE)
$14.30-$0.002 (-0.01%)
RARE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.30 | ||
Change | -$0.10 (-0.69%) | ||
Open | $14.43 | ||
High | $14.70 | ||
Low | $14.13 | ||
Previous Close | $14.40 | ||
Volume | 3,253,692 | ||
30-Day Average Volume | 4,214,237 | ||
1-Week Change | -6.54% | ||
1-Month Change | -46.96% | ||
1-Year Change | -52.82% | ||
3-Year Change | -64.90% | ||
5-Year Change | -85.94% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $1.3B | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $112.0M | ||
Net Income | -$92.0M | ||
Free Cash Flow | -$98.0M | ||
EBIT | -$91.0M | ||
EBITDA | -$83.0M | ||
Net Working Capital | $255.0M | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 11 | ||
P/B | -5 | ||
P/E | -16 | ||
PEG | -0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue